6/14/2022 2:48:37 AM
Evotec Enters Into Drug Discovery Collaboration With Janssen
5/19/2022 1:46:36 AM
Evotec And Almirall Enter Multi-target Alliance In Medical Dermatology
5/17/2022 1:45:24 AM
Evotec, Sernova Announce Strategic Partnership For IPSC-based Beta Cell Replacement Therapy
5/11/2022 1:05:54 AM
Evotec Q1 Group Revenues Increase 24% To EUR 164.7 Mlm
4/12/2022 1:08:53 AM
Evotec AG FY Group Revenues Up 23% To EUR 618.0 Mln
4/8/2022 1:52:07 AM
Evotec Achieves Programme Designation In Neuroscience Collaboration With Bristol Myers Squibb
3/21/2022 2:52:06 AM
Evotec Gets EUR 3 Mln Milestone Payment For Bayer Starting Phase II Clinical Development Of DNP Programme
3/2/2022 1:33:02 AM
Evotec Confirms Goals Of Action Plan 2025 At Capital Markets Day
3/1/2022 1:48:34 AM
Evotec Collaborates With UoB To Expand Molecular Patient Database In Field Of Kidney Diseases With Nephrotic Syndrome
2/4/2022 7:37:48 AM
Bayer Discontinues Clinical Development Candidate Eliapixant